Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.02 USD | +9.26% | +0.33% | -40.57% |
05-14 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
05-09 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.57% | 453M | |
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Transcript : Editas Medicine, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-12-2022 10